Abstract

Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
Julie Panepinto ... Ashima Singh
Blood | VOL. 136
Julie Panepinto, et. al.Julie Panepinto ... Ashima Singh
05 Nov 2020
Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
Sarah Sewaralthahab ... Hedy Smith
Blood | VOL. 136
Sarah Sewaralthahab, et. al.Sarah Sewaralthahab ... Hedy Smith
05 Nov 2020
Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithm.
Benjamin Carpentier ... Gylna Loko
American journal of hematology | VOL. 97
Benjamin Carpentier, et. al.Benjamin Carpentier ... Gylna Loko
15 Apr 2022
Renal Functional Decline in Sickle Cell Disease and Trait.
Karl A Nath ... Gregory M Vercellotti
Journal of the American Society of Nephrology : JASN | VOL. 31
Karl A Nath, et. al.Karl A Nath ... Gregory M Vercellotti
24 Jan 2020
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Tamer Othman ... Ibrahim Aldoss
British journal of haematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Ibrahim Aldoss
29 May 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
View more papers